There had been a lot of hope for aticaprant, with GlobalData previously touting it as the most promising pipeline product for MDD due to its novel MOA and focus on anhedonia, a hard-to-treat symptom.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback